Skip to main content

Table 1 The clinical information of validation samples

From: Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis

Index Classification Case number Percentage
(%)
Index Classification Case number Percentage
(%)
Sex male 37 69.80 Tumor differentiation status high 1 1.89
female 16 30.20 medium 34 64.20
Age <  60 24 45.28 low 12 22.61
≥ 60 28 52.83 None 6 11.30
None 1 1.90 Hypertension Yes 20 37.70
Tumor stage I-II 15 28.30 No 31 58.50
III-IV 36 67.90 None 2 3.80
None 2 3.80 Diabetes Yes 5 9.40
Primary diagnosis Mucinous adenocarcinoma 7 13.20 No 46 86.80
Other adenocarcinoma 44 83.00 None 2 3.80
None 2 3.80 Coronary heart disease Yes 6 11.30
KPS score 80 3 5.70 No 45 84.90
90 23 43.40 None 2 3.80
95 12 22.60 Other diseases Yes 15 28.30
None 15 28.30 No 36 67.90
Drinking habit Yes 30 56.60 None 2 3.80
NO 12 22.60 Therapeutic method Neoadjuvant chemotherapy + Operation 4 5.70
None 11 20.80 Operation only 24 45.30
Smoking habit Yes 24 45.30 Operation + chemotherapy 23 43.40
NO 23 43.40 Neoadjuvant chemotherapy+Operation+Targeting 2 3.80
None 6 11.30 OS <  1 year 17 32.08
Tumor size <  5 cm 23 43.40 1–3 years 16 30.19
≥ 5 cm 26 49.10 ≥ 3 years 5 9.43
None 4 7.50 None 5 9.43
  1. OS, survival time; None indicated unclear or unknown